James E. Patrick

1.7k total citations
50 papers, 1.4k citations indexed

About

James E. Patrick is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, James E. Patrick has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 16 papers in Pharmacology and 12 papers in Analytical Chemistry. Recurrent topics in James E. Patrick's work include Pharmacogenetics and Drug Metabolism (17 papers), Analytical Methods in Pharmaceuticals (11 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). James E. Patrick is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Analytical Methods in Pharmaceuticals (11 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). James E. Patrick collaborates with scholars based in United States, China and United Kingdom. James E. Patrick's co-authors include Kevin B. Alton, Swapan K. Chowdhury, Robert Iannucci, Shmuel Zbáida, Anima Ghosal, Paul Statkevich, Melton B. Affrime, Teddy Kosoglou, S. K. Chowdhury and Ragu Ramanathan and has published in prestigious journals such as Analytical Chemistry, The American Journal of Cardiology and Journal of Chromatography A.

In The Last Decade

James E. Patrick

49 papers receiving 1.3k citations

Peers

Countries citing papers authored by James E. Patrick

Since Specialization

Citations

This map shows the geographic impact of James E. Patrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Patrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Patrick more than expected).

Fields of papers citing papers by James E. Patrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Patrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Patrick. The network helps show where James E. Patrick may publish in the future.

Co-authorship network of co-authors of James E. Patrick

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Patrick. A scholar is included among the top collaborators of James E. Patrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Patrick. James E. Patrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disposition of loratadine in healthy volunteers 2007 ·Xenobiotica ·Ragu Ramanathan, Larisa Reyderman, Kenneth Kulmatycki, (unknown), (unknown), S. K. Chowdhury, Kevin B. Alton, Mark Wirth, Robert P. Clement, Paul Statkevich, James E. Patrick	28
2	Metabolism and excretion of loratadine in male and female mice, rats and monkeys 2005 ·Xenobiotica ·Ragu Ramanathan, (unknown), (unknown), S. K. Chowdhury, Kevin B. Alton, Kathe Stauber, James E. Patrick	24
3	IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL) 2004 ·Drug Metabolism and Disposition ·Anima Ghosal, (unknown), Yuan Yuan, (unknown), Robert Iannucci, Swapan K. Chowdhury, Kevin B. Alton, James E. Patrick, Shmuel Zbáida	139
4	Disposition and pharmacokinetics of temozolomide in rat 2004 ·Xenobiotica ·Larisa Reyderman, Paul Statkevich, C. Mohan Thonoor, James E. Patrick, Vijay Batra, Mark Wirth	50
5	IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF EZETIMIBE (ZETIA) 2004 ·Drug Metabolism and Disposition ·Anima Ghosal, (unknown), Yuan Yuan, (unknown), Robert Iannucci, Swapan K. Chowdhury, Kevin B. Alton, James E. Patrick, Shmuel Zbáida	108
6	Identification of human UDP‐glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3‐hydroxydesloratadine 2004 ·Biopharmaceutics & Drug Disposition ·Anima Ghosal, Yuan Yuan, (unknown), (unknown), (unknown), Swapan K. Chowdhury, Kevin B. Alton, James E. Patrick, Shmuel Zbáida	30
7	Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes 2003 ·Biopharmaceutics & Drug Disposition ·Anima Ghosal, (unknown), Yuan Yuan, Xiaowen Lu, (unknown), James E. Patrick, Shmuel Zbáida	63
8	Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin 2002 ·British Journal of Clinical Pharmacology ·Teddy Kosoglou, Ingo Meyer, Enrico P. Veltri, Paul Statkevich, Bo Yang, Yali Zhu, L. Mellars, Stephen E. Maxwell, James E. Patrick, David L. Cutler, Vijay Batra, Melton B. Affrime	91
9	High-performance liquid chromatographic method for the quantification of unbound evernimicin in human plasma ultrafiltrate 2002 ·Journal of Chromatography B ·(unknown), (unknown), Kevin B. Alton, Narendra S. Kishnani, James E. Patrick	2
10	Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects 2002 ·Drug Metabolism and Disposition ·James E. Patrick, Teddy Kosoglou, Kathe Stauber, Kevin B. Alton, Stephen Maxwell, Yali Zhu, Paul Statkevich, Robert Iannucci, Swapan K. Chowdhury, Melton B. Affrime, Mitchell N. Cayen	133
11	Fragmentation of N‐oxides (deoxygenation) in atmospheric pressure ionization: Investigation of the activation process 2001 ·Rapid Communications in Mass Spectrometry ·Wei Tong, Swapan K. Chowdhury, (unknown), (unknown), Kevin B. Alton, James E. Patrick	53
12	The Plasma Concentration and LDL-C Relationship in Patients Receiving Ezetimibe 2001 ·The Journal of Clinical Pharmacology ·Farkad Ezzet, David Wexler, Paul Statkevich, Teddy Kosoglou, James E. Patrick, Leslie Lipka, L. Mellars, Enrico P. Veltri, Vishal Batra	49
13	High-performance liquid chromatographic determination of N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-l-methionine, the active plasma metabolite of a prodrug atriopeptidase inhibitor (SCH 42495), using a thiol selective (Au/Hg) amperometric detector 1992 ·Journal of Chromatography B Biomedical Sciences and Applications ·Kevin B. Alton, (unknown), (unknown), James E. Patrick	5
14	Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam 1991 ·Journal of Pharmacokinetics and Biopharmaceutics ·John G. Wagner, Derek Ganes, Kamal K. Midha, (unknown), J. Chris Sackellares, (unknown), Melton B. Affrime, James E. Patrick	10
15	Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations 1989 ·The American Journal of Cardiology ·Bruce D. Given, George Perentesis, (unknown), Jerry Herron, James E. Patrick, William G. Kramer, Melton B. Affrime	6
16	Secretion of Dilevalol in Breast Milk 1988 ·The Journal of Clinical Pharmacology ·Elaine Radwanski, (unknown), Melton B. Affrime, George Perentesis, Samson Symchowicz, James E. Patrick	7
17	High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection 1988 ·Journal of Chromatography B Biomedical Sciences and Applications ·Kevin B. Alton, (unknown), James E. Patrick	9
18	Comparative steady state bioavailability of conventional and controlled‐release formulations of albuterol 1987 ·Biopharmaceutics & Drug Disposition ·Mark L. Powell, (unknown), (unknown), Richard Gural, Samson Symchowicz, James E. Patrick	14
19	Biotransformation of bromperidol in rat, dog, and man. 1983 ·Drug Metabolism and Disposition ·Fiona Wong, (unknown), Charles J. Shaw, James E. Patrick	21
20	BIOTRANSFORMATION OF A 1,5-BENZODIAZEPINE, TRIFLUBAZAM, BY MAN 1975 ·Drug Metabolism and Disposition ·Kevin B. Alton, (unknown), Charles J. Shaw, James E. Patrick, J.L. McGuire	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact